Precision Medicine Diagnostics Market, by Solutions (Diagnostic Solutions, Therapeutic Solutions, Services, Software), by Technology (Gene Sequencing, Flow Cytometry, Mass Spectrometry, Nucleic Acid Testing, Bioinformatics, Protein Microarrays), by Application (Oncology, Infectious Diseases, Immunology, Neurology, Cardiology, Other Applications) and, by End-user (Medical Centers, Research and Clinical Laboratories, Pharma and Biotech Companies): Opportunity Analysis and Industry Forecast, 2023-2032

The global Precision medicine diagnostics market report covers market size, share, growth rate (CAGR %) for various segments at regional and country levels. The market overview section of the report highlights the qualitative aspect of the market along with various market dynamics such as drivers, restraints, market trends, and opportunities. Furthermore, the section covers the market snapshot and key findings, in terms of investment opportunity and market overview. The report further includes a detailed competitive landscape comprising comprehensive profiles of leading players. The top players are assessed depending on their revenue size, market share, geographical presence, recent developments & strategic initiatives, and overall contribution to the market.

Key Companies identified in the report are Thermo Fisher Scientific Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Illumina, Inc., Agilent Technologies, Inc., Oxford Nanopore Technologies Ltd., BIO-RAD Laboratories Inc., Pacific Biosciences of California, Inc., Eurofins Scientific SE., PerkinElmer, Inc.

Market Snapshot

Key Segments Covered

by solutions, by technology, by application, by end-user

Key Inclusions

• Qualitative as well as quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors

• Analysis at regional and country level, which highlights the consumption of the product or service in the different geographies.

• Extensive company profiles section, which includes different pointers such as company overview, key executive, company snapshot, business performance, product/service portfolio, R&D spending, and key strategies and developments of the major market players.

• The current and anticipated market outlook of the Precision medicine diagnostics market with respect to recent developments which include analysis of drivers, market trends, and growth opportunities

• Free 20% customization and post-sales support

  Precision Medicine Diagnostics Market, by Solutions Report Highlights

Aspects	Details
By Solutions	Diagnostic Solutions Therapeutic Solutions Services Software
By Technology	Gene Sequencing Flow Cytometry Mass Spectrometry Nucleic Acid Testing Bioinformatics Protein Microarrays
By Application	Oncology Infectious Diseases Immunology Neurology Cardiology Other Applications
By End-user	Medical Centers Research and Clinical Laboratories Pharma and Biotech Companies
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Oxford Nanopore Technologies Ltd., Illumina, Agilent Technologies, Eurofins Scientific SE., Pacific Biosciences of California, BIO-RAD Laboratories Inc., PerkinElmer, Thermo Fisher Scientific Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd.

^*Terms and Conditions Apply